Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults

NCT01717950 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hookworm Infection
Hookworm Disease

Interventions

BIOLOGICAL: Na-APR-1 (M74)/Alhydrogel®
BIOLOGICAL: Gluco-Pyranosylphospho-Lipid A Aqueous Formulation

Sponsor

Baylor College of Medicine

Collaborators

[object Object]